Global Indian Nasal Spray Market is valued USD 0.786 billion in 2016 is anticipated to grow USD 1.65 billion with the compounded annual growth of 9.7 % over the forecast period 2018-2025.

New York 16 Aug 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Indian Nasal Spray Market industry is poised to raise USD 1.65 billion by 2025. The primary factors driving the market growth of Indian Nasal Spray include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. About 20-30% of Indian population suffers from at least one allergic disease. On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market

To view the summary or to request a sample copy of this report, please click the link mentioned below:

Global Indian Nasal Spray Market Size study, by Product (Decongestion Nasal Spray, Salt Water Solution/Saline Nasal Spray, Steroid Nasal Spray). by Availability (Prescribed, Over the Counter), by Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitors, Anticholinergic) and by Regional Forecasts 2018-2025

The industry is seeming to be fairly competitive. Some of the leading market Glaxo Smith Kline, Ranbaxy., Cipla, Lupin, Sun pharmaceuticals Industries Ltd., Zydus Cadiala Pharmaceuticals, Macleods and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.

Key findings of the study:

  • About 20-30% of Indian population suffers from at least one allergic disease..

Bizwit Research & Consulting LLP has considered following segments for the study:

By Product:

  • Decongestion Nasal Spray
  • Salt Water Solution/Saline Nasal Spray
  • Steroid Nasal Spray

By Availability:

  • Prescribed
  • Over the Counter

By Therapeutic Class:

  • Antihistamine
  • Nasal Steroids
  • Mast Cell Inhibitor
  • Anticholinergic

Regional Outlook:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest of the World

To get a sample of this report or to purchase a copy of the study, you can directly contact us. Or mail to us at:

how can we help you?

For any specific query or to receive regular updates of our latest titles fill the details on the contact form or in the subscription box down below. Trust us, we hate spams too. You will only get the regular updates and quality contents.